Back to search

Article

Survival Analysis of TACE Monotherapy vs. Combination Therapy in BCLC B and C Stage Hepatocellular Carcinoma: A Retrospective Cohort Study

2024-10-21

Abstract excerpt

<title>Abstract</title> <p>Introduction Standard treatments provide limited benefits for patients with intermediate or advanced hepatocellular carcinoma (HCC). This retrospective observational study aimed to assess potential improvements associated with systemic therapies in patients receiving transarterial chemoembolization (TACE) for initially unresectable HCC. Methods Between February 2019 to March 2023, we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d38827f-f631-5b5e-a0d0-843eac6f2dc8
DOI
10.21203/rs.3.rs-5011990/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Survival Analysis of TACE Monotherapy vs. Combination Therapy in BCLC B and C Stage Hepatocellular Carcinoma: A Retrospective Cohort StudyDOI 10.21203/rs.3.rs-5011990/v1
Therapeutic efficacy of transarterial chemoembolization-radiofrequency ablation combination in hepatocellular carcinoma with a high tumor burdenSemantic proximity
Notable-HCC: A phase Ib trial of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with early stage resectable hepatocellular carcinomaSemantic proximity
Preliminary Evaluation of Local Treatment Combined with Systemic Therapy for Tumor Recurrence after Surgery for Dual-Phenotype Hepatocellular CarcinomaSemantic proximity
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombusSemantic proximity
Hepatectomy combined with targeted and immunotherapy for CNLC stage IIIb hepatocellular carcinoma: a single-arm clinical trials protocolSemantic proximity
Benefits of combination therapy with immune checkpoint inhibitors and predictive role of tumour mutation burden in hepatocellular carcinoma: A systematic review and meta-analysis.Semantic proximity
First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma: a real-world studySemantic proximity
Comparison of Clinical Efficacy of Molecular Targeted Drugs Combined with Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemoembolization Alone for Primary Liver CancerSemantic proximity
Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy (HAIC) Versus Systemic Therapy in Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-AnalysisSemantic proximity
Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center StudySemantic proximity
Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.Semantic proximity
Comparing the efficacy of five first-line treatment regimens for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trialsSemantic proximity
Select a neighboring publication to make it the new centre.